Skip to main content
. 2014 Feb 26;8(2):171–191. doi: 10.1007/s11832-014-0566-3

Table 3.

The characteristics and healing outcome of UBCs located in the humerus (n = 497)

Treatment outcome
Success Failure
Sexa
 Male 132 (79.0) 35 (21.0)
 Female 51 (82.3) 11 (17.7)
Locationa
 Metaphysis 145 (73.6) 52 (26.4)
 Diaphysis 31 (93.9) 2 (6.1)
Activitya
 Active 31 (72.1) 12 (27.9)
 Latent 31 (81.6) 7 (18.4)
Treatment
 Surgical curettage 107 (77.0) 32 (23.0)
 No graft 12 (63.2) 7 (36.8)
 Allograft 23 (95.8) 1 (4.2)
 Autograft 35 (74.5) 12 (25.5)
 Mix allograft + autograft 11 (57.9) 8 (42.1)
 Allograft + bone marrow 7 (78.5) 1 (12.5)
 Ceramic 6 (100) 0 (0)
 Osteoset pellets 13 (81.2) 3 (18.8)
Injection
 MPA 86 (81.1) 20 (18.9)
 Bone marrow 16 (72.7) 6 (27.3)
 Bone marrow + DBM 28 (100) 0 (0)
 MPA + bone marrow 2 (100) 0 (0)
 IM nail 88 (96.7) 3 (3.3)
 Screws 12 (85.7) 2 (7.1)
 Cyst excision 39 (92.9) 3 (14.7)
 Conservative 12 (22.6) 41 (77.3)
 Proximal metaphysis 6 (12.8) 41 (78.2)
 Diaphysis 4 (100) 0 (0)

Data were retrieved from these references: [6, 8, 9, 12, 13, 15, 21, 24, 25, 27, 30, 31, 38, 42, 43, 45, 46, 51, 54, 61, 65, 67]

MPA methylprednisolone, DBM demineralized bone matrix, IM nail Intramedulary nail, Screws continuous decompression with cannulated screws

aThe exact location of the cyst was not determined in all the papers; therefore, the percentages did not add up to 100 %